Endo and Penwest Enter Into Agreement with Barr to Settle Patent Litigation Over Opana(R) ER
Press Release Source: Endo Pharmaceuticals On Tuesday April 13, 2010, 8:33 am
CHADDS FORD, Pa., April 13 /PRNewswire-FirstCall/ -- Endo Pharmaceuticals (Nasdaq:ENDP - News) and Penwest Pharmaceuticals (Nasdaq:PPCO - News) announced today that the companies have settled litigation with Barr Laboratories, Inc. regarding the production and sale of generic formulations of Opana® ER (oxymorphone hydrochloride) Extended Release Tablets CII.
Under the terms of the settlement, Endo and Penwest have agreed to grant Barr a license to sell a generic of Opana® ER on or after Sept. 15, 2012, or earlier under certain circumstances.
surf's up......crikey
